Collision of the COVID-19 and Addiction Epidemics
- PMID: 32240293
- PMCID: PMC7138334
- DOI: 10.7326/M20-1212
Collision of the COVID-19 and Addiction Epidemics
Abstract
People with substance use disorder may be especially susceptible to COVID-19, and compromised lung function from COVID-19 could also put at risk those who have opioid use disorder and methamphetamine use disorder. This commentary describes the risks of the collision of the COVID-19 and addiction epidemics.
Keywords: Addiction; Brain; COVID-19; Cancer prevention; Drug therapy; Health care; Lungs; Opioids; Population statistics; Pulmonary diseases.
References
-
- Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72 314 cases from the Chinese Center for Disease Control And Prevention. JAMA. 2020. [PMID: 32091533] doi:10.1001/jama.2020.2648. - PubMed
-
- National Institute of Allergy and Infectious Diseases. Coronaviruses. Reviewed 13 March 2020. Accessed at www.niaid.nih.gov/diseases-conditions/coronaviruses. on 18 March 2020.
-
- Leece P, Cavacuiti C, Macdonald EM, et al; Canadian Drug Safety and Effectiveness Research Network. Predictors of opioid-related death during methadone therapy. J Subst Abuse Treat. 2015;57:30-5. [PMID: 26014916] doi:10.1016/j.jsat.2015.04.008. - PubMed
-
- Zibbell J, Howard J, Duhart Clarke S, et al. Non-fatal opioid overdose and associated health outcomes: final summary report. U.S. Department of Health and Human Services. 4 September 2019. Accessed at https://aspe.hhs.gov/basic-report/non-fatal-opioid-overdose-and-associat.... on 18 March 2020.